Wegovy 0.5 mg ndc 00169?

Wegovy® (Semaglutide) – 0.5 mg

How to Use

1. Reconstitution – The pen is pre‑filled; no reconstitution needed.
2. Administration – Shake the pen, remove the safety cap, and inject 0.5 mg once weekly at the same time of day.
3. Storage – Keep in the refrigerator (2 °C – 8 °C). Do not freeze.
4. Disposal – Use a sharps container for used pens.

Common Side Effects

Most side effects are mild to moderate and often improve after the first few weeks.

Serious Risks & Warnings

Drug Interactions

What to Tell Your Healthcare Provider

• Medical history: thyroid disorders, pancreatitis, diabetes, pregnancy plans.
• Current meds: especially glucose‑lowering drugs.
• Allergies: to semaglutide or other GLP‑1 agents.
• Lifestyle: diet, exercise, adherence to weekly injection schedule.

Pharmacokinetics (brief)

• Absorption: Peak plasma concentration ~48 h post‑dose.
• Half‑life: ~1 week (allowing once‑weekly dosing).
• Metabolism: Proteolytic cleavage; not hepatically metabolized.

FAQ Snapshot

Bottom Line

Wegovy 0.5 mg (NDC 00169‑0112‑01) is a once‑weekly, subcutaneous GLP‑1 receptor agonist that helps adults with obesity or overweight to achieve sustainable weight loss when used with lifestyle changes. It’s generally safe, but watch for GI upset, pancreatitis, gallbladder issues, and hypoglycemia (if used with other glucose‑lowering drugs). Always discuss your full medical history and all current medications with your prescribing clinician before starting Wegovy.